MaxLife NAD+ 120 Capsules – Liposomal NAD+ & Trans-Resveratrol

NAD+ and NMN

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in energy metabolism whose levels decline with age. NMN (nicotinamide mononucleotide) and nicotinamide riboside are precursors that the body converts to NAD+.

Resveratrol

Resveratrol is a polyphenol found in grape skins and Japanese knotweed (Polygonum cuspidatum).

NAD+ and NMN

A 2026 systematic review of trials of oral NMN found good short-term tolerability but no clear broad metabolic benefits, with preliminary signals on blood pressure and insulin resistance¹. Evidence for injected or nasal NAD+ products is very limited.

Resveratrol

An umbrella review of meta-analyses found high-certainty evidence that resveratrol reduced waist circumference, lowered blood pressure in people with type 2 diabetes and reduced total cholesterol in overweight adults².

NAD+ and NMN

Trials are short and small; larger, longer trials are needed to confirm efficacy and long-term safety¹.

Resveratrol

Effects are modest and differ by population and dose².

NAD+ and NMN

Short-term oral NMN was well tolerated in trials¹. Injectable NAD+ products are not quality-controlled medicines.

Resveratrol

Generally well tolerated; high doses can cause digestive upset and may interact with blood thinners.

Flagged for compliance review: this product is listed as a food supplement in our catalogue, but its EU status (food supplement, novel food or medicinal product) has not been verified. No benefits or health claims are made.

NAD+ and NMN

NMN and NAD+ are not authorised novel foods in the EU³. Injectable NAD+ products are not authorised medicines⁴.

Resveratrol

Trans-resveratrol is authorised as a novel food in the EU under specific conditions³. No health claim for this ingredient is authorised in the EU⁵; it is sold under national food-supplement rules⁶.